To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Long-term mortality and c… - University of Gothenburg, Sweden Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Long-term mortality and causes of death in isolated GHD, ISS, and SGA patients treated with recombinant growth hormone during childhood in Belgium, The Netherlands, and Sweden: preliminary report of 3 countries participating in the EU SAGhE study.

Journal article
Authors Lars Sävendahl
Marc Maes
Kerstin Albertsson-Wikland
Birgit Borgström
Jean-Claude Carel
Séverine Henrard
Niko Speybroeck
Muriel Thomas
Gladys Zandwijken
Anita Hokken-Koelega
Published in The Journal of clinical endocrinology and metabolism
Volume 97
Issue 2
Pages E213-7
ISSN 1945-7197
Publication year 2012
Published at Institute of Clinical Sciences, Department of Pediatrics
Pages E213-7
Language en
Links dx.doi.org/10.1210/jc.2011-2882
Keywords Adolescent, Adult, Adverse Drug Reaction Reporting Systems, statistics & numerical data, Belgium, epidemiology, Cause of Death, trends, Child, Cohort Studies, Dwarfism, Pituitary, drug therapy, epidemiology, mortality, Europe, epidemiology, Female, Growth Disorders, drug therapy, epidemiology, mortality, Human Growth Hormone, adverse effects, deficiency, therapeutic use, Humans, Infant, Newborn, Infant, Small for Gestational Age, growth & development, Male, Netherlands, epidemiology, Pilot Projects, Recombinant Proteins, adverse effects, therapeutic use, Survival Rate, trends, Sweden, epidemiology, Time Factors, Young Adult
Subject categories Pediatrics

Abstract

The long-term mortality in adults treated with recombinant GH during childhood has been poorly investigated. Recently released data from the French part of the European Union Safety and Appropriateness of GH treatments in Europe (EU SAGhE) study have raised concerns on the long-term safety of GH treatment.

Page Manager: Webmaster|Last update: 9/11/2012
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?